Showing results (681-690 of 1,995) with videos related to

Sort By:
Pageof 200
The Lancet. Neurology|July 14, 2018
Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trialRichard Hughes, Marinos C Dalakas, Ingemar Merkies, et al.
The Lancet. Neurology|June 24, 2018
Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1: a multicentre, single-blind, randomised trialKees Okkersen, Cecilia Jimenez-Moreno, Stephan Wenninger, et al.
The Lancet. Neurology|October 24, 2003
Pain processing in dementia and its relation to neuropathologyErik J A Scherder, Joseph A Sergeant, Dick F Swaab
The Lancet. Neurology|August 28, 2003
Treatment of Alzheimer's disease: current status and new perspectivesElio Scarpini, Philip Scheltens, Howard Feldman
The Lancet. Neurology|August 28, 2003
The brain in diabetes: molecular changes in neurons and their implications for end-organ damageJoshua P Klein, Stephen G Waxman
The Lancet. Neurology|November 26, 2003
Cognitive impairment during epileptiform discharges: is it ever justifiable to treat the EEG?Colin D Binnie
The Lancet. Neurology|November 6, 2007
Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trialPaul H Gordon, Dan H Moore, Robert G Miller, et al.
The Lancet. Neurology|October 13, 2007
Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trialJames Kennedy, Michael D Hill, Karla J Ryckborst, et al.
The Lancet. Neurology|November 23, 2007
Medulloblastoma in childhood: new biological advancesJohn R Crawford, Tobey J MacDonald, Roger J Packer
The Lancet. Neurology|October 15, 2008
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodiesJosep Dalmau, Amy J Gleichman, Ethan G Hughes, et al.
Pageof 200